Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The updated mRNA vaccines from Moderna and Pfizer-BioNTech target the KP ... Why we see such relatively rapid waning immunity with SARS-CoV-2 isn’t clear. “I’ve seen reports of multiple infections ...

Liberty Media Corporation ("Liberty Media" or "Liberty") (NASDAQ: FWONA, FWONK, LLYVA, LLYVK) today reported third quarter 2024 results. Headlines include(1): Completed ...

BioNTech (NASDAQ:BNTX) said it has agreed to buy bispecific antibody developer Biotheus for up to $950M, including $150M in potential milestone payments. Under the deal, BioNTech (BNTX) will pay $800M ...

No FDA-approved rapid tests exist that specifically test for H5N1, and the first near-point-of-care test for mpox was ...

FDA reccommends checking the shelf life of COVID anitigen test close to expiring due to some test with different dates from ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech ... are hoping the same rapid development and deployment ...

The Company is also announcing that clinical test article manufacturing for all planned Study ... President of Lexaria Bioscience Corp. "Their nearly round-the-clock work has resulted in a rapid ...

You probably have a cabinet full of rapid COVID-19 tests you’ve accumulated. The expiration dates have come closer and closer, with some tests even reaching them. The Food and Drug Administration, ...

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...